7774 Japan Tissue Engineering Co., Ltd. - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

7774

TSE Growth

Japan Tissue Engineering Co., Ltd.

635

JPY

-23

(-3.50%)

Mar 13, 3:30 pm JST

3.98

USD

Mar 13, 2:30 am EDT

Result

PTS

outside of trading hours

632

Mar 13, 7:17 pm JST

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2022	2,103	-498	-494	-497	-12.3	0	Apr 26, 2022	J-GAAP
Mar, 2023	2,032	-728	-725	-729	-18.0	0	Apr 27, 2023	J-GAAP
Mar, 2024	2,514	144	147	143	3.5	0	Apr 30, 2024	J-GAAP
Mar, 2025	2,455	-238	-234	-255	-6.3	0	Apr 30, 2025	J-GAAP
Mar, 2026 Guidance	2,210	-550	-540	-540	-13.3	0	Jan 30, 2026	J-GAAP
YoY	-10.0%	-131.1%	-130.8%	-111.8%	-111.4%

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Mar, 2021	Apr 27, 2020	ー	ー	ー	ー	0	J-GAAP
- - - -	Jan 29, 2021	2,333	-497	-493	-497	0	J-GAAP
Results	Apr 28, 2021	2,257	-466	-462	-466	0	J-GAAP
Mar, 2022	Apr 28, 2021	Available in future release
	Jan 31, 2022
Results	Apr 26, 2022
Mar, 2023	Apr 26, 2022
	Jan 27, 2023
Results	Apr 27, 2023
Mar, 2024	Apr 27, 2023
	Aug 7, 2023
Results	Apr 30, 2024
Mar, 2025	Apr 30, 2024
	Jan 31, 2025
Results	Apr 30, 2025
Mar, 2026	Apr 30, 2025	3,000	150	160	145	0	J-GAAP
	Jan 30, 2026	2,210	-550	-540	-540	0	J-GAAP

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Mar, 2003	0	－	Available in future release
Mar, 2004	0	－
Mar, 2005	40	－
Mar, 2006	68	+70.0
Mar, 2007	103	+51.5
Mar, 2008	111	+7.8
Mar, 2009	114	+2.7
Mar, 2010	211	+85.1
Mar, 2011	351	+66.4
Mar, 2012	473	+34.8
Mar, 2013	563	+19.0
Mar, 2014	1,008	+79.0
Mar, 2015	1,321	+31.1
Mar, 2016	1,430	+8.3
Mar, 2017	2,135	+49.3
Mar, 2018	2,271	+6.4
Mar, 2019	2,357	+3.8
Mar, 2020	2,309	-2.0
Mar, 2021	2,257	-2.3
Mar, 2022	2,103	-6.8
Mar, 2023	2,032	-3.4
Mar, 2024	2,514	+23.7
Mar, 2025	2,455	-2.3
Mar, 2026 Guidance	2,210	-10.0	-550	-131.1	-540	-130.8	-13.3	-111.1

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
Mar, 2024	2,514	144	5.73	2.38	2.06	0.36	3.5
Mar, 2025	2,455	-238	-9.7	-4.28	-3.78	0.36	-6.3
Mar, 2026 Guidance	2,210	-550	-25	-10.25	-9.17	0.38	-13.3

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	2,514	312	309	276	6.8
Fiscal Year	Mar, 2024	Mar, 2017	Mar, 2017	Mar, 2017	Mar, 2017

Second Half

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2022	1,060	-308	-306	-308	-7.6	0	Apr 27, 2023	J-GAAP
Oct - Mar, 2023	1,268	154	156	154	3.8	0	Apr 30, 2024	J-GAAP
Oct - Mar, 2024	1,294	-31	-28	-30	-0.7	0	Apr 30, 2025	J-GAAP
Oct - Mar, 2025 Guidance	1,212	-174	-171	-169	-4.2	0	Jan 30, 2026	J-GAAP
YoY	-6.3%	-461.3%	-510.7%	-463.3%	-462.2%

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
Mar, 2023	-728	502	-622	1,124	2,034	29.55	J-GAAP
Mar, 2024	144	32	274	-242	2,066	29.56	J-GAAP
Mar, 2025	-238	-380	-148	-232	1,685	25.88	J-GAAP

Actual Performance and Financial Trends

Accumulated Results 3rd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Dec, 2023	1,785	-51	-50	-53	-1.3	ー	Jan 30, 2024	J-GAAP
Apr - Dec, 2024	1,706	-331	-330	-350	-8.6	ー	Jan 31, 2025	J-GAAP
Apr - Dec, 2025	1,509	-563	-552	-556	-13.7	ー	Jan 30, 2026	J-GAAP
YoY	-11.5%	-70.1%	-67.3%	-58.9%	-58.9%

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Jan - Mar, 2024	729	195	197	196	4.8	26.7	Apr 30, 2024	J-GAAP
Apr - Jun, 2024	442	-193	-192	-211	-5.2	-43.7	Jul 30, 2024	J-GAAP
Jul - Sep, 2024	719	-14	-14	-14	-0.4	-1.9	Oct 31, 2024	J-GAAP
Oct - Dec, 2024	545	-124	-124	-125	-3.1	-22.8	Jan 31, 2025	J-GAAP
Jan - Mar, 2025	749	93	96	95	2.3	12.4	Apr 30, 2025	J-GAAP
Apr - Jun, 2025	426	-244	-241	-242	-6.0	-57.3	Jul 30, 2025	J-GAAP
Jul - Sep, 2025	572	-132	-128	-129	-3.2	-23.1	Oct 31, 2025	J-GAAP
Oct - Dec, 2025	511	-187	-183	-185	-4.6	-36.6	Jan 30, 2026	J-GAAP
YoY	-6.2%	-50.8%	-47.6%	-48.0%	-48.1%

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Jan - Mar, 2021	874	+8.7	Available in future release
Apr - Jun, 2021	478	+26.8
Jul - Sep, 2021	502	-6.9
Oct - Dec, 2021	615	+31.7
Jan - Mar, 2022	508	-41.9
Apr - Jun, 2022	422	-11.7
Jul - Sep, 2022	550	+9.6
Oct - Dec, 2022	471	-23.4
Jan - Mar, 2023	589	+15.9
Apr - Jun, 2023	662	+56.9
Jul - Sep, 2023	584	+6.2
Oct - Dec, 2023	539	+14.4
Jan - Mar, 2024	729	+23.8
Apr - Jun, 2024	442	-33.2
Jul - Sep, 2024	719	+23.1
Oct - Dec, 2024	545	+1.1
Jan - Mar, 2025	749	+2.7
Apr - Jun, 2025	426	-3.6
Jul - Sep, 2025	572	-20.4
Oct - Dec, 2025	511	-6.2	-187	-50.8	-183	-47.6	-4.6	-48.4

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	981	510	509	479	11.8
Fiscal Year	Mar, 2017	Mar, 2017	Mar, 2017	Mar, 2017	Mar, 2017

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
Mar, 2023	146.20	86.3	6,883	5,937	-1,810	ー	Apr 27, 2023	J-GAAP
Mar, 2024	149.73	87.0	6,988	6,080	-1,666	ー	Apr 30, 2024	J-GAAP
Mar, 2025	143.44	89.5	6,512	5,825	-1,922	ー	Apr 30, 2025	J-GAAP
Apr - Dec, 2025	ー	89.4	5,890	5,268	-556	ー	Jan 30, 2026	J-GAAP

Japan Tissue Engineering Co., Ltd.(7774) Financial Results